{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:44Z","timestamp":1789154384346,"version":"build-2803163510"},"reference-count":122,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Autoimmune hepatitis (AIH) is a chronic immune-inflammatory disease of the liver, generally considered a rare condition. The clinical manifestation is extremely varied and can range from paucisymptomatic forms to severe hepatitis. Chronic liver damage causes activation of hepatic and inflammatory cells leading to inflammation and oxidative stress through the production of mediators. This results in increased collagen production and extracellular matrix deposition leading to fibrosis and even cirrhosis. The gold standard for the diagnosis of fibrosis is liver biopsy; however, there are serum biomarkers, scoring systems, and radiological methods useful for diagnosis and staging. The goal of AIH treatment is to suppress fibrotic and inflammatory activities in the liver to prevent disease progression and achieve complete remission. Therapy involves the use of classic steroidal anti-inflammatory drugs and immunosuppressants, but in recent years scientific research has focused on several new alternative drugs for AIH that will be discussed in the review.<\/jats:p>","DOI":"10.3390\/jcm12051979","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T03:29:00Z","timestamp":1677727740000},"page":"1979","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Autoimmune Hepatitis and Fibrosis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-0649","authenticated-orcid":false,"given":"Rinaldo","family":"Pellicano","sequence":"first","affiliation":[{"name":"Unit of Gastroenterology, Citt\u00e0 della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Ferro","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cicerchia","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5261-718X","authenticated-orcid":false,"given":"Simone","family":"Mattivi","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-6716","authenticated-orcid":false,"given":"Sharmila","family":"Fagoonee","sequence":"additional","affiliation":[{"name":"Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Centre, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2450-5911","authenticated-orcid":false,"given":"Marilena","family":"Durazzo","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bpg.2010.07.011","article-title":"Autoimmune hepatitis","volume":"24","author":"Strassburg","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbadis.2004.01.005","article-title":"Oxidant stress in type I autoimmune hepatitis: The link between necroinflammation and fibrogenesis?","volume":"1689","author":"Pemberton","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: Direct antifibrotic agents and targeted therapies","volume":"68","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s10620-016-4254-7","article-title":"Targeting hepatic fibrosis in autoimmune hepatitis","volume":"61","author":"Thandassery","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: Functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fphys.2012.00213","article-title":"The role of chemokines in acute liver injury","volume":"3","author":"Saiman","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5604\/16652681.1226814","article-title":"Management strategies for liver fibrosis","volume":"16","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: Autoimmune hepatitis","volume":"63","author":"Lohse","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: Proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20132021 update","volume":"75","author":"Panel","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2004.11.023","article-title":"Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis","volume":"42","author":"Tsikrikoni","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_19","first-page":"1780","article-title":"Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis","volume":"51","author":"Sakaguchi","year":"2004","journal-title":"Hepato-Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, Y.S., Ni, S.Y., Meng, Y., Shi, X.L., Zhao, X.W., Luo, H.H., and Li, X. (2013). Angiotensin II facilitates fibrogenic effect of TGF-\u03b21 through enhancing the down-regulation of BAMBI caused by LPS: A new pro-fibrotic mechanism of angiotensin II. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076289"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_22","first-page":"519a","article-title":"Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab","volume":"62","author":"Bowlus","year":"2015","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tadokoro, T., Morishita, A., and Masaki, T. (2021). Diagnosis and therapeutic management of liver fibrosis by MicroRNA. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158139"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1089\/ars.2021.0023","article-title":"Circulating extracellular vesicles contain liver-derived RNA species as indicators of severe cholestasis-induced early liver fibrosis in mice","volume":"36","author":"Fagoonee","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13446","article-title":"Systematic review with meta-analysis: Direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B","volume":"43","author":"Houot","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2011.08.007","article-title":"Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard","volume":"56","author":"Poynard","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Vali, Y., Lee, J., Boursier, J., Spijker, R., Verheij, J., Brosnan, M., Anstee, Q., Bossuyt, P., Zafarmand, M., and on behalf of the LITMUS Systematic Review Team (2021). FibroTest for evaluating fibrosis in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112415"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/17474124.2021.1880894","article-title":"Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: A meta-analysis","volume":"15","author":"Dong","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_29","first-page":"51","article-title":"APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis","volume":"18","author":"Kassem","year":"2006","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_30","first-page":"301","article-title":"Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: Diagnostic accuracy of different scores","volume":"66","author":"Durazzo","year":"2020","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.23736\/S0031-0808.20.04171-3","article-title":"Non-invasive biomarkers in predicting non-alcoholic steatohepatitis and assessing liver fibrosis: Systematic review and meta-analysis","volume":"63","author":"Ismaiel","year":"2021","journal-title":"Panminerva Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12072-018-9907-5","article-title":"Systematic review: Diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis","volume":"13","author":"Wu","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"892454","DOI":"10.3389\/fimmu.2022.892454","article-title":"Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/MEG.0000000000001437","article-title":"Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients","volume":"31","author":"Yuan","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12935-018-0558-3","article-title":"Prognostic role of RDW in hematological malignancies: A systematic review and meta-analysis","volume":"18","author":"Ai","year":"2018","journal-title":"Cancer Cell Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4254\/wjh.v10.i1.82","article-title":"Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis","volume":"10","author":"Iida","year":"2018","journal-title":"World J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.gastrohep.2021.10.001","article-title":"Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysis","volume":"45","author":"Chen","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MEG.0000000000001599","article-title":"Elevated mean platelet volume to platelet ratio predicts advanced fibrosis in chronic hepatitis C","volume":"32","author":"Gozdas","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_40","first-page":"e927946-1","article-title":"Red blood cell distribution width-to-platelet ratio and other laboratory indices associated with severity of histological hepatic fibrosis in patients with autoimmune hepatitis: A retrospective study at a single center","volume":"26","author":"Li","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00261-016-1019-x","article-title":"Imaging of autoimmune hepatitis and overlap syndromes","volume":"42","author":"Malik","year":"2017","journal-title":"Abdom. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1148\/radiology.172.2.2526349","article-title":"Cirrhosis: Diagnosis with sonographic study of the liver surface","volume":"172","author":"Cestari","year":"1989","journal-title":"Radiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10620-012-2525-5","article-title":"Hepatocellular carcinoma and other malignancies in autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1055\/s-0043-103952","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017","volume":"38","author":"Dietrich","year":"2017","journal-title":"Ultraschall Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ultrasmedbio.2020.11.013","article-title":"Comparison of 2-D shear wave elastography and point shear wave elastography for assessing liver fibrosis","volume":"47","author":"Zhou","year":"2021","journal-title":"Ultrasound Med. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Park, D.W., Lee, Y.J., Chang, W., Park, J.H., Lee, K.H., Kim, Y.H., Kang, N.K., Chung, J.W., Jang, H.Y., and Ahn, S. (2019). Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212771"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17474124.2020.1779589","article-title":"Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis","volume":"14","author":"Xing","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00247-020-04959-9","article-title":"Diagnostic accuracy of two-dimensional shear wave elastography in detecting hepatic fibrosis in children with autoimmune hepatitis, biliary atresia and other chronic liver diseases","volume":"51","author":"Galina","year":"2021","journal-title":"Pediatr. Radiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12072-015-9643-z","article-title":"Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: A systematic review and meta-analysis of a diagnostic test","volume":"9","author":"Xu","year":"2015","journal-title":"Hepatol. Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy","volume":"54","author":"Tsochatzis","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/apt.13488","article-title":"Systematic review with meta-analysis: The diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B","volume":"43","author":"Li","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis","volume":"71","author":"Lee","year":"2022","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e13446","DOI":"10.1111\/eci.13446","article-title":"A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease","volume":"51","author":"Gu","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/liv.12003","article-title":"Transient elastography: A meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease","volume":"33","author":"Shi","year":"2013","journal-title":"Liver Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.12659\/MSM.907300","article-title":"Transient elastography (FibroScan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients","volume":"23","author":"Guo","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.22056","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","author":"Sagir","year":"2008","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/liv.14726","article-title":"Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis","volume":"41","author":"Janik","year":"2021","journal-title":"Liver Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","author":"Wong","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.26343","article-title":"Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution","volume":"58","author":"Arena","year":"2013","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/liv.13260","article-title":"Transient elastography for the diagnosis of liver fibrosis: A systematic review of economic evaluations","volume":"37","author":"Coyle","year":"2017","journal-title":"Liver Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3184\/003685017X14993478654307","article-title":"Magnetic resonance spectroscopy","volume":"100","author":"Rhodes","year":"2017","journal-title":"Sci. Prog."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: A systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3748\/wjg.v23.i5.859","article-title":"Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis","volume":"23","author":"Wang","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiol.10091351","article-title":"Nonalcoholic fatty liver disease: Detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling","volume":"256","author":"Sevastianova","year":"2010","journal-title":"Radiology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2214\/AJR.07.2262","article-title":"Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy","volume":"190","author":"Orlacchio","year":"2008","journal-title":"Am. J. Roentgenol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/00365521.2017.1315738","article-title":"31Phosphorus magnetic resonance spectroscopy of the liver for evaluating inflammation and fibrosis in autoimmune hepatitis","volume":"52","author":"Puustinen","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.22112","article-title":"Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C","volume":"47","author":"Madrazo","year":"2008","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s00330-020-06665-4","article-title":"Assessment of liver fibrosis severity using computed tomography\u2013based liver and spleen volumetric indices in patients with chronic liver disease","volume":"30","author":"Son","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3748\/wjg.v26.i18.2247","article-title":"Computed tomography vs liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis","volume":"26","author":"Li","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.cgh.2008.08.005","article-title":"Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis","volume":"6","author":"Andersson","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1517\/14656566.2014.931938","article-title":"Current and prospective pharmacotherapy for autoimmune hepatitis","volume":"15","author":"Czaja","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"134","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early-and late-stage primary biliary cirrhosis","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can. J. Gastroenterol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","article-title":"Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group","volume":"73","author":"Lohse","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhep.2009.03.011","article-title":"Mycophenolate mofetil to the rescue in autoimmune hepatitis: A fresh sprout on the decision tree","volume":"51","author":"Czaja","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MEG.0000000000001367","article-title":"Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: A meta-analysis","volume":"31","author":"Yu","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1097\/TP.0000000000001379","article-title":"Impact of immune- modulatory drugs on regulatory T cell","volume":"100","author":"Furukawa","year":"2016","journal-title":"Transplantation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","article-title":"Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis","volume":"21","author":"Sherman","year":"1994","journal-title":"J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.151.2.1039","article-title":"Cyclosporin A-induced autoimmune disease in mice","volume":"151","author":"Bucy","year":"1993","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.4049\/jimmunol.162.11.6926","article-title":"Cyclosporin A-induced autologous graft-versus-host disease: A prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants","volume":"162","author":"Wu","year":"1999","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig. Dis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10620-015-4022-0","article-title":"Refractory autoimmune hepatitis: Beyond standard therapy","volume":"61","author":"Rubin","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S0168-8278(18)30652-4","article-title":"Rituximab treatment experience in patients with complicated type 1 autoimmune hepatitis in Europe and North America","volume":"68","author":"Than","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells","volume":"62","author":"Marceau","year":"2015","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: Analysis of 233 cases","volume":"86","author":"Soria","year":"2007","journal-title":"Medicine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2017.07.012","article-title":"JKB-122 is effective, alone or in combination with prednisolone in Con A-induced hepatitis","volume":"812","author":"Hsu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/liv.14062","article-title":"Autoimmune hepatitis: Current and future therapeutic options","volume":"39","author":"Doycheva","year":"2019","journal-title":"Liver Int."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor be-longing to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.humimm.2007.03.010","article-title":"Elevated serum BAFF levels in patients with autoimmune hepatitis","volume":"68","author":"Migita","year":"2007","journal-title":"Hum. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/liv.12122","article-title":"1,25-dihydroxyvitamin D3 and its nuclear receptor repress human alpha1 (I) collagen expres- sion and type I collagen formation","volume":"33","author":"Potter","year":"2013","journal-title":"Liver Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","article-title":"Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis","volume":"59","author":"Efe","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_110","first-page":"CD011564","article-title":"Vitamin D supplementation for chronic liver diseases in adults","volume":"8","author":"Bjelakovic","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Moriya, K., Nishimura, N., Namisaki, T., Takaya, H., Sawada, Y., Kawaratani, H., Kaji, K., Shimozato, N., Sato, S., and Furukawa, M. (2021). Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112465"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.aohep.2019.08.011","article-title":"Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis","volume":"19","author":"Diglio","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s10620-021-07112-0","article-title":"Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients","volume":"67","author":"Gelow","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment. Pharm. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"569104","DOI":"10.3389\/fimmu.2020.569104","article-title":"Bifidobacterium animalis ssp. Lactis 420 mitigates autoimmune hepatitis through regulating intestinal barrier and liver immune cells","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"108863","DOI":"10.1016\/j.jnutbio.2021.108863","article-title":"Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability","volume":"98","author":"Liu","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.imlet.2017.08.005","article-title":"Sodium butyrate ameliorates S100\/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway","volume":"190","author":"Wu","year":"2017","journal-title":"Immunol. Lett."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcb.27338","article-title":"Silencing of microRNA-375 affects immune function in mice with liver failure by upregulating astrocyte elevated gene-1 through reducing apoptosis of Kupffer cells","volume":"120","author":"Ke","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"BSR20190763","DOI":"10.1042\/BSR20190763","article-title":"Down-regulation of microRNA-138 improves immunologic function via negatively targeting p53 by regulating liver macrophage in mice with acute liver failure","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jcmm.14750","article-title":"MicroRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation","volume":"24","author":"Tu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"105910","DOI":"10.1016\/j.phrs.2021.105910","article-title":"Epigenetic regulation in fibrosis progress","volume":"173","author":"Xue","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/5\/1979\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:56Z","timestamp":1760121956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/5\/1979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":122,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jcm12051979"],"URL":"https:\/\/doi.org\/10.3390\/jcm12051979","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}